التفاصيل البيبلوغرافية
| العنوان: |
Glucagon‐like peptide‐1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting? |
| المؤلفون: |
Borner, Tito, Tinsley, Ian C., Doyle, Robert P., Hayes, Matthew R., De Jonghe, Bart C. |
| المصدر: |
British Journal of Pharmacology; Feb2022, Vol. 179 Issue 4, p542-556, 15p, 4 Diagrams |
| مصطلحات موضوعية: |
GLYCEMIC control, GLUCAGON-like peptide-1 receptor, TYPE 2 diabetes, GLUCAGON-like peptide-1 agonists, NAUSEA |
| الشركة/الكيان: |
UNITED States. Food & Drug Administration |
| مستخلص: |
Introduced less than two decades ago, glucagon‐like peptide‐1 receptor agonists rapidly reshaped the field of Type 2 diabetes mellitus (T2DM) care by providing glycaemic control in tandem with weight loss. However, FDA‐approved GLP‐1 receptor agonists are often accompanied by nausea and emesis and, in some lean T2DM patients, by undesired anorexia. Importantly, the hypophagic and emetic effects of GLP‐1 receptor agonists are caused by activation of central GLP‐1 receptors. This review summarizes two different approaches to mitigate the incidence and severity of nausea and emesis related to GLP‐1 receptor agonists: conjugation with vitamin B12, or related corrin ring‐containing compounds ('corrination'), and development of dual agonists of GLP‐1 receptors with glucose‐dependent insulinotropic polypeptide (GIP). Such approaches could lead to the generation of GLP‐1 receptor agonists with improved therapeutic efficacy, thus decreasing treatment attrition, increasing patient compliance and extending treatment to a broader population of T2DM patients. The data reviewed show that it is possible to pharmacologically separate the emetic effects of GLP‐1 receptor agonists from their glucoregulatory action. LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetocTest [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Pharmacology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder